Robert J. Spiegel's Net Worth
Estimate Recalculated Mar 29, 2026 11:31PM EST
Who is Robert J. Spiegel
Robert J. Spiegel has an estimated net worth of $1.8 Million. This is based on reported shares across multiple companies, which include RenovoRx, Inc., Capstone Therapeutics Corp., Sucampo Pharmaceuticals, Inc., GERON CORP, PTC THERAPEUTICS, INC., Edge Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Ayala Pharmaceuticals, Inc., Athenex, Inc., Ayala Pharmaceuticals, Inc., and Talon Therapeutics, Inc..
SEC CIK
Robert J. Spiegel's CIK is 0001492256
Past Insider Trading and Trends
2023 was Robert J. Spiegel's most active year for acquiring shares with 15 total transactions. Robert J. Spiegel's most active month to acquire stocks was the month of May. 2018 was Robert J. Spiegel's most active year for disposing of shares, totalling 16 transactions. Robert J. Spiegel's most active month to dispose stocks was the month of August. 2014 saw Robert J. Spiegel paying a total of $5,133,155.50 for 199,754 shares, this is the most they've acquired in one year. In 2018 Robert J. Spiegel cashed out on 415,130 shares for a total of $1,522,290.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
